MK-5172 sodium salt - CAS 1425038-27-2
Catalog number:
1425038-27-2
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C38H49N6NaO9S
Molecular Weight:
788.89
COA:
Inquire
Targets:
HCV
Description:
In biochemical assays, MK-5172 was effective against a panel of major genotypes and variants engineered with common resistant mutations observed in clinical studies with other NS3/4a protease inhibitors. In the replicon assay, MK-5172 demonstrated subnanomolar to low-nanomolar EC50s against genotypes 1a, 1b, and 2a. In rats, MK-5172 showed a plasma clearance of 28 ml/min/kg and plasma half-life of 1.4 hr. When dosed p.o. at 5 mg/kg, the plasma exposure of MK-5172 was good with an AUC of 0.7 uM.hr. The liver exposure of the compound was quite good (23 uM at 4 hr), and MK-5172 remained in liver 24 hr after a single p.o. 5 mg/kg dose. At 24 hr, the liver concentration of MK-5172 was 0.2 uM, which was over 25-fold higher than the IC50 in the replicon assay with 50% NHS. When dosed to dogs, MK-5172 showed low clearance of 5 ml/min/kg and a 3 hr half-life after i.v. 2 mg/kg dosing and had good plasma exposure (AUC=0.4 uM.hr) after a p.o. 1 mg/kg dose.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Grazoprevir sodium salt; MK5172 sodium salt; MK 5172 sodium salt
MSDS:
Inquire
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HCV Products


CAS 863329-66-2 PSI-6206

PSI-6206
(CAS: 863329-66-2)

PSI-6206 (RO2433) is a selective HCV RNA polymerase inhibitor. It is the unphosphorylated parent compound of triphosphate analog PSI-7409, which is a potent inh...

Ombitasvir
(CAS: 1258226-87-7)

Ombitasvir, a NS5A inhibitor, could be effective in the treatment of HCV as an antiviral agent. IC50: 14 pM and 5 pM (EC50) for genotype 1a-H77 and 1b-Con1 resp...

Ravidasvir HCl
(CAS: 1303533-81-4)

Avidasvir is a second-generation Hepatitis C virus NS 5 protein inhibitor. In Sep 2016, Phase-II/III clinical trials in Hepatitis C in Malaysia was on-going.

CAS 478182-28-4 R-1479

R-1479
(CAS: 478182-28-4)

R1479 is a potent and highly specific inhibitor of HCV replication in cell culture, and that its triphosphate is a potent and highly selective inhibitor of NS5B...

CAS 20724-73-6 2'-C-Methylcytidine

2'-C-Methylcytidine
(CAS: 20724-73-6)

2'-C-Methylcytidine, also called as NM107, inhibits the replication of HCV RNA and exerts inhibitory activity and cytotoxicity against HCV 1b replicon cells (IC...

CAS 1441674-54-9 Ledipasvir acetone

Ledipasvir acetone
(CAS: 1441674-54-9)

Against JFH1/3a-NS5A, DCV was more potent (EC(50) = 0.52 nM) than GS-5885 (EC(50) = 141 nM). DCV sensitivity was increased against JFH1/3a-NS5A-M28V (EC50 = 0.0...

CAS 1502654-87-6 Ledipasvir D-tartrate

Ledipasvir D-tartrate
(CAS: 1502654-87-6)

Against JFH1/3a-NS5A, DCV was more potent (EC(50) = 0.52 nM) than GS-5885 (EC(50) = 141 nM). DCV sensitivity was increased against JFH1/3a-NS5A-M28V (EC50 = 0.0...

Vedroprevir
(CAS: 1098189-15-1)

Vedroprevir is a selective hepatitis C virus (HCV) NS3 protease inhibitor. It is a pharmaceutical drug that is used in the treatment of hepatitis C virus in pat...

CAS 1190308-01-0 PSI-7976

PSI-7976
(CAS: 1190308-01-0)

PSI-7976 is an inhibitor of HCV RNA replication with EC50 value of 1.07μM. PSI-7851 is a phosphoramidate prodrug of PSI-7411 and has potent anti-hepatitis C vir...

CAS 1009119-65-6 Daclatasvir dihydrochloride

Daclatasvir dihydrochloride
(CAS: 1009119-65-6)

Daclatasvir dihydrochloride is a highly selective inhibitor of HCV NS5A with EC50 of 9-50 pM, for a broad range of HCV replicon genotypes and the JFH-1 genotype...

CAS 630420-16-5 Asunaprevir

Asunaprevir
(CAS: 630420-16-5)

Asunaprevir is a potent hepatitis C virus (HCV) non-structural protein protease inhibitor currently in Phase III clinical trials for the treatment of HCV infect...

CAS 958002-33-0 Beclabuvir

Beclabuvir
(CAS: 958002-33-0)

Beclabuvir is a potent, non-nucleotide inhibitor of HCV NS5B which is currently in Phase III clinical trials for the treatment of chronic HCV infection. Beclabu...

CAS 1015073-42-3 PSI-7409

PSI-7409
(CAS: 1015073-42-3)

PSI-7409, the active 5′-triphosphate metabolite of PSI-7851, is a potent inhibitor of the HCV NS5B RNA dependent RNA polymerase.

CAS 1009119-64-5 Daclatasvir

Daclatasvir
(CAS: 1009119-64-5)

Daclatasvir, inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV).

CAS 1190307-88-0 sofosbuvir

sofosbuvir
(CAS: 1190307-88-0)

PSI-7977 is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investiga...

ACH-806
(CAS: 870142-71-5)

ACH-806 is a Hepatitis C virus NS3 protein inhibitor. It can inhibit viral RNA replication in HCV replicon cells and is active in genotype 1 HCV-infected patien...

CAS 923590-37-8 Vaniprevir

Vaniprevir
(CAS: 923590-37-8)

Vaniprevir is a non-covalent competitive inhibitor of the hepatitis C virus (HCV) NS3/4A protease. It is a macrocyclic hepatitis C virus NS3/4a protease inhibit...

CAS 940908-79-2 R-7128

R-7128
(CAS: 940908-79-2)

R-7128 is a selective nucleoside analog inhibitor of the hepatitis C virus (HCV) NS5B RNA-dependent RNA polymerase, with activity across all HCV genotypes. It i...

CAS 402957-28-2 Telaprevir

Telaprevir
(CAS: 402957-28-2)

VX-950 is a potent, selective, peptidomimetic inhibitor of the hepatitis C virus (HCV) NS3-4A serine protease, and it demonstrated excellent antiviral activity ...

CAS 1350514-68-9 MK-5172

MK-5172
(CAS: 1350514-68-9)

In biochemical assays, MK-5172 was effective against a panel of major genotypes and variants engineered with common resistant mutations observed in clinical stu...

Chemical Structure

CAS 1425038-27-2 MK-5172 sodium salt

Quick Inquiry

Verification code

Featured Items